Literature DB >> 32126303

From role of gut microbiota to microbial-based therapies in type 2-diabetes.

Hamed Ebrahimzadeh Leylabadlo1, Sarvin Sanaie2, Fatemah Sadeghpour Heravi3, Zainab Ahmadian4, Reza Ghotaslou5.   

Abstract

The incidence of type 2 diabetes mellitus (T2DM) has increased dramatically at an alarming level around the world.T2DM is associated with changeable risk factors in lifestyle as well as genetic and family associated risk factors. More importantly, imbalanced or impaired gut microbial distribution (dysbiosis) has been reported as a contributing risk factor in insulin resistance progression in T2DM. Dysbiosis may restructure the metabolic and functional pathways in the intestine which are involved in the development of T2DM. However, several studies have indicated the constructive and helpful effect of prebiotics, probiotics, and fecal microbiota transplantation (FMT) on the improvement of gut microbiota (GM) and accordingly host metabolism. In this review, the association between GM and T2DM have been evaluated and the role of prebiotics, probiotics and FMT, as potential therapeutic approaches have been discussed. Relevant studies were obtained randomly from online databases such as PubMed/Medline and ISI Web of Science.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Microbiome; Microbiota; Prebiotics; Probiotics; Type 2 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32126303     DOI: 10.1016/j.meegid.2020.104268

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

Review 1.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

Review 2.  Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus.

Authors:  Haoran Jiang; Miaomiao Cai; Boyuan Shen; Qiong Wang; Tongcun Zhang; Xiang Zhou
Journal:  Foods       Date:  2022-08-13

3.  Fecal microbiota composition is related to brown adipose tissue 18F-fluorodeoxyglucose uptake in young adults.

Authors:  L Ortiz-Alvarez; F M Acosta; J R Ruiz; B Martinez-Tellez; H Xu; G Sanchez-Delgado; R Vilchez-Vargas; A Link; J Plaza-Díaz; J M Llamas; A Gil; I Labayen; P C N Rensen
Journal:  J Endocrinol Invest       Date:  2022-10-15       Impact factor: 5.467

Review 4.  Anthocyanins as Antidiabetic Agents-In Vitro and In Silico Approaches of Preventive and Therapeutic Effects.

Authors:  Hélder Oliveira; Ana Fernandes; Natércia F Brás; Nuno Mateus; Victor de Freitas; Iva Fernandes
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

Review 5.  Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.

Authors:  Dan-Cristian Vodnar; Laura Mitrea; Bernadette-Emoke Teleky; Katalin Szabo; Lavinia-Florina Călinoiu; Silvia-Amalia Nemeş; Gheorghe-Adrian Martău
Journal:  Front Cell Infect Microbiol       Date:  2020-12-09       Impact factor: 5.293

Review 6.  Whole Alga, Algal Extracts, and Compounds as Ingredients of Functional Foods: Composition and Action Mechanism Relationships in the Prevention and Treatment of Type-2 Diabetes Mellitus.

Authors:  Aránzazu Bocanegra; Adrián Macho-González; Alba Garcimartín; Juana Benedí; Francisco José Sánchez-Muniz
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 7.  Role and Mechanism of Gut Microbiota in Human Disease.

Authors:  Yinwei Chen; Jinghua Zhou; Li Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

8.  The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.

Authors:  Patricia M Bock; Gabriela H Telo; Rafaela Ramalho; Mariana Sbaraini; Gabriel Leivas; Andreza F Martins; Beatriz D Schaan
Journal:  Diabetologia       Date:  2020-10-13       Impact factor: 10.122

Review 9.  The Effect of Dietary Fibre on Gut Microbiota, Lipid Profile, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Omorogieva Ojo; Osarhumwese Osaretin Ojo; Nazanin Zand; Xiaohua Wang
Journal:  Nutrients       Date:  2021-05-26       Impact factor: 5.717

10.  The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Omorogieva Ojo; Qian-Qian Feng; Osarhumwese Osaretin Ojo; Xiao-Hua Wang
Journal:  Nutrients       Date:  2020-10-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.